Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neurofilaments as biomarkers in multiple sclerosis.
Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.
Fingolimod (FTY720) stimulates ca(2+)/calcineurin signaling in fission yeast.
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
The Implication of Vitamin D and Autoimmunity: a Comprehensive Review.
Cortical excitability changes over time in progressive multiple sclerosis.
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Impact of Clear, Loud and Slow Speech on Scaled Intelligibility and Speech Severity in Parkinson's Disease and Multiple Sclerosis.
Bioinformatics challenges for genome-wide association studies.
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
Impact of acupuncture by using life-energy (qi) oriental needle on the paralysis of rats with experimental autoimmune encephalomyelitis.
Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.
XIMINO (minocycline hydrochloride) capsule, extended release [Ranbaxy Laboratories Inc.]
Multiple sclerosis: basic knowledge and new insights in perioperative management.
Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study.
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients.
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
[Levels of Beclin 1 and LC3 in peripheral blood mononuclear cells of patients with multiple sclerosis and neuromyelitis optica and its significance].
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis.
[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].
FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring-reply.
Pages
« first
‹ previous
…
170
171
172
173
174
175
176
177
178
…
next ›
last »